Xenotransplantation is the use of animal organs, tissues or cells for transplantion into humans to treat a variety of medical conditions. If proven efficacious, the technique could be used as one means of alleviating the disparity between the growing demand for transplantable organs, tissues and cells, and the availability of human-origin transplants world-wide. Just as the practicality and efficacy of the technology need to be investigated, so too does the potential for associated infectious disease risk. While much remains to be learned about the microbiological risk associated with xenotransplantation, the elements to be incorporated into xenotransplantation risk management schemes can be considered, using what is currently known about the infectious agents potentially relevant to the xenotransplantation setting.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.20506/rst.19.1.1216 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!